Resistell News:

Venturelab's series about Switzerland’s most inspiring entrepreneurs and founders continues with Danuta Cichocka, the co-founder and CEO of Resistell AG.

Venturelab's series about Switzerland’s most inspiring entrepreneurs and founders continues with Danuta Cichocka, the co-founder and CEO of Resistell AG.
Resistell News:

Venturelab's series about Switzerland’s most inspiring entrepreneurs and founders continues with Danuta Cichocka, the co-founder and CEO of Resistell AG.

The Muttenz-based biotech startup proposes an alternative to culture-based antibiograms, the current gold standard in antibiotic susceptibility testing. The EPFL spin-off offers a diagnostic device, the rapid AST method, which is based on the detection of movement caused by living bacterial cells. The new method reduces the time taken to get a result from days to minutes, shows which specific antibiotic is effective against the bacteria, and significantly improves the chances of patients’ survival.
Venturelab's series about Switzerland’s most inspiring entrepreneurs and founders continues with Danuta Cichocka, the co-founder and CEO of Resistell AG.
curves

Latest news

31.05.2018 - Resistell the winner of Venture Kick stage 2
4th June 2018

31.05.2018 - Resistell the winner of Venture Kick stage 2

31.05.2018 - Resistell's team has won the Venture Kick stage 2!
1st June 2018

Antibiotic resistance crisis worsening because of collapse in supply

The Access To Medicine foundation warns that antibiotic supply chain issues are helping to fuel the rise in AMR Their solution? ‘The right products need to reach the right patients at the right time’ - exactly what Resistell is working toward.
24th May 2018

The Antibiotics Problem

Discover how the search for a rapid diagnostic system lies at the heart of tackling antibiotic resistance, a problem which is predicted to kill 10 million people a year by 2050. Resistell is working to create the innovative solutions needed.
Containing Unusual Resistance
20th April 2018

Containing Unusual Resistance

The Centers for Disease Control and Prevention (CDC) have outlined the ways in which health departments can prevent the spread of antibiotic resistance. Rapid identification of resistant bacteria is at the heart of their strategy. Resistell is helping to make that a reality.
New mechanism of drug resistance discovered in Pseudomonas aeruginosa
18th April 2018

New mechanism of drug resistance discovered in Pseudomonas aeruginosa

Bacteria such as Pseudomonas aeruginosa are becoming resistant to the widely used antibiotic Ciprofloxacin (CIP). As resistance like this spreads the pioneering work of Resistell becomes more urgent. See how we’re leading the search for faster and more accurate diagnosis.
A prototype for rapid diagnosis is being used in hospitals
5th April 2018

A prototype for rapid diagnosis is being used in hospitals

SNSF NRP 72 Antimicrobial Resistance about Resistell.
#sciencenews #research #antimicrobials #nfp72
5th April 2018

#sciencenews #research #antimicrobials #nfp72

Real world testing of Resistell methods is the next step in refining and making actual use of our innovations. Our device produces the resistance profile of a pathogen within a few hours instead of days.
AMR Conference in Berlin
10th March 2018

AMR Conference in Berlin

On 02.03.2018 the Resistell team presented at Novel Antimicrobials and AMR Diagnostics conference in Berlin. Our MVP attracted a lot of attention!
Novel Antimicrobials & AMR Diagnostics Conference
28th February 2018

Novel Antimicrobials & AMR Diagnostics Conference

We invite you to meet us in Berlin at Novel Antimicrobials & AMR Diagnostics Conference (02.03.2018). We welcome you at our stand and invite to see our pitch.
#BerlinConference #AMR #BerlinConferenceonLifeSciences
26th February 2018

#BerlinConference #AMR #BerlinConferenceonLifeSciences

Resistell on the 11th Berlin Conference on Life Sciences 💉 💉 Join us in Berlin on 02.03 at 16:00 at Fraunhofer-Forum Berlin SpreePalais!!! 😉
Resistell passed Venture Kick stage 1
2nd February 2018

Resistell passed Venture Kick stage 1

Four new startups get CHF 10,000
Press about us: EPFL EMBA: a new innovation-minded approach
22nd January 2018

Press about us: EPFL EMBA: a new innovation-minded approach

Three questions for Danuta Cichocka (EMBA’16), founder of Resistell
Resistell moves into BASEL INKUBATOR
20th November 2017

Resistell moves into BASEL INKUBATOR

We are pleased to announce our new location in BASEL INKUBATOR, Hochbergerstr. 60c, CH 4057 Basel
Swiss Startup Days 2017
23rd October 2017

Swiss Startup Days 2017

Resistell qualified to take part in a pitching battle at Swiss Startup Days 2017